ArticleSignal transduction and targeted therapy2022

DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2.

Gang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.